News - Elelyso

Filter

Current filters:

Elelyso

Popular Filters

Protalix and Pfizer expand Elelyso agreement

07-12-2012

Israeli drug developer Protalix BioTherapeutics (NYSE-AMEX: OLX) said yesterday that it has entered into…

ElelysoLicensingPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesResearch

Protalix gains Israeli approval for Gaucher drug Elelyso

01-10-2012

ael-based Protalix BioTherapeutics (NYSE-AMEX: OLX) has received marketing authorization from the Israeli…

BiotechnologyElelysoPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationRest of the World

$25 million milestone for Protalix following US approval of Elelyso

13-06-2012

Israel-based Protalix BioTherapeutics (TASE:PLX) has received a $25 million milestone payment from global…

ElelysoFinancialPfizerPharmaceuticalProtalix BioTherapeuticsRare diseases

Elelyso: a new therapeutic option for patients with Gaucher disease

09-05-2012

The US Food and Drug Administration recently approved Protalix BioTherapeutic's (NYSE-AMEX: OLX) Elelyso…

CerezymeElelysoGenzymeMarkets & MarketingPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesShireVpriv

Back to top